{"name": "Cardiokine",
 "permalink": "cardiokine",
 "crunchbase_url": "http://www.crunchbase.com/company/cardiokine",
 "homepage_url": "http://www.cardiokine.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@cardiokine.com",
 "phone_number": "215-399-1200 ",
 "description": "",
 "created_at": "Thu Jan 05 05:35:14 UTC 2012",
 "updated_at": "Thu Jan 05 05:35:14 UTC 2012",
 "overview": "\u003Cp\u003ECardiokine, Inc., a specialty pharmaceutical company, engages in the development of pharmaceuticals for the prevention and treatment of cardiovascular diseases. Its products include lixivaptan, an orally active vasopressin receptor antagonist for patients with congestive heart failure who suffer from hyponatremia. The company was founded in 2004 and is headquartered in Philadelphia, Pennsylvania.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       28],
      "assets/images/resized/0016/8879/168879v1-max-150x150.png"],
     [[250,
       47],
      "assets/images/resized/0016/8879/168879v1-max-250x250.png"],
     [[283,
       54],
      "assets/images/resized/0016/8879/168879v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President and CEO",
    "person":
     {"first_name": "Amber",
      "last_name": "Salzman",
      "permalink": "amber-salzman",
      "image": null}},
   {"is_past": true,
    "title": "director ",
    "person":
     {"first_name": "Andrew",
      "last_name": "Schiff",
      "permalink": "andrew-schiff",
      "image":
       {"available_sizes":
         [[[95,
            144],
           "assets/images/resized/0026/5594/265594v1-max-150x150.jpg"],
          [[95,
            144],
           "assets/images/resized/0026/5594/265594v1-max-250x250.jpg"],
          [[95,
            144],
           "assets/images/resized/0026/5594/265594v1-max-450x450.jpg"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition":
  {"price_amount": null,
   "price_currency_code": "USD",
   "term_code": null,
   "source_url": "https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=32\u0026aid=DJFVW00020120104e814og0uw\u0026r=Rss\u0026s=DJFVW",
   "source_description": "Cornerstone Therapeutics Acquires Cardiokine For Cardiovascular Drug ",
   "acquired_year": 2012,
   "acquired_month": 1,
   "acquired_day": 4,
   "acquiring_company":
    {"name": "Cornerstone Therapeutics",
     "permalink": "cornerstone-therapeutics",
     "image":
      {"available_sizes":
        [[[150,
           35],
          "assets/images/resized/0016/8878/168878v1-max-150x150.png"],
         [[250,
           59],
          "assets/images/resized/0016/8878/168878v1-max-250x250.png"],
         [[264,
           63],
          "assets/images/resized/0016/8878/168878v1-max-450x450.png"]],
       "attribution": null}}},
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "30 South 15th Street ",
    "address2": "15th Floor ",
    "zip_code": "19102 ",
    "city": "Philadelphia",
    "state_code": "PA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}